Baystate Wealth Management’s Biomerica BMRA Stock Holding History

Baystate Wealth Management’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$250	Buy	+25	New	+$189	﹤0.01%	1250

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Baystate Wealth Management's BMRA Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in Biomerica (BMRA) in Q4 2023: 25 shares worth $250. The stake represents ﹤0.01% of the portfolio and ranks #1250 among its holdings.

33 funds tracked by Wall St. Rank hold BMRA as of Q4 2023.

Baystate Wealth Management held 25 shares of Biomerica worth $250 as of Q4 2023.
Biomerica was a new Baystate Wealth Management position in Q4 2023.
Biomerica made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1250 holding.
33 funds tracked by Wall St. Rank held Biomerica as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.